Form 4: Hims & Hers CMO Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll sold 10,021 shares of Class A Common Stock for $36.71 per share under a pre-arranged trading plan.

Summary

• Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., disposed of 10,021 shares of Class A Common Stock.
• The transaction occurred on December 17, 2025, at a price of $36.71 per share.
• Following this sale, Patrick Harrison Carroll beneficially owns 169,940 shares of Class A Common Stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on May 19, 2025.

Sentiment

Score: 5

Explanation: The transaction is an insider stock sale, but it was conducted under a pre-arranged 10b5-1 trading plan, which typically indicates a planned liquidity event rather than a reaction to new information. This makes the sentiment neutral for the company's immediate prospects.

Positives

• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reactive sale based on new, undisclosed information.

Negatives

• The transaction represents a reduction in insider ownership, with the Chief Medical Officer selling 10,021 shares.

Risks

• NA

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: A reduction in insider ownership, though pre-planned, could be viewed with slight caution by some investors, but generally has a neutral impact given the 10b5-1 plan.

Key Dates

Recommendation

The sale by the Chief Medical Officer was executed under a pre-arranged 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new company information. While it reduces insider ownership, it does not inherently signal a change in the company's fundamental outlook. Therefore, a 'hold' recommendation is appropriate as this transaction alone does not provide sufficient new information to alter an investment thesis.

Keywords

Hims & Hers, HIMS, insider trading, Form 4, stock sale, Patrick Harrison Carroll, Chief Medical Officer, 10b5-1 plan